CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes
about
Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cellsIdentification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cellsA common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cellsMolecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicityImmunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cellsA novel phosphotyrosine motif with a critical amino acid at position -2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1Polymorphism and domain variability of human killer cell inhibitory receptorsNKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptorDAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cellsA human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cellsTumor-primed NK cells: waiting for the green lightDevelopment of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoiresInhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatasesSignal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.The influence of the maternal uterine immune response on placentation in human subjects.The contribution of gammadelta T cells to the pathogenesis of EAE and MS.Development and function of CD94-deficient natural killer cellsDual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells.The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis.Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis.The search for the missing 'missing-self' receptor on natural killer cells.HLA class I specificity for natural killer cell receptor CD94/NKG2A: two for one in more ways than one.HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2APeptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis.Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptorThe direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity.Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cellsRecognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysisModulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog.Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4.Human natural killer cell development.Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells.Natural killer cells: versatile roles in autoimmune and infectious diseases.A bird's eye view of NK cell receptor interactions with their MHC class I ligands.A novel negative regulator molecule, Cho-1, is involved in the cytotoxicity by human natural killer cells but not in cytotoxic T lymphocytes.The human CD94 gene encodes multiple, expressible transcripts including a new partner of NKG2A/B.Impaired MHC class I (H-2Dd)-mediated protection against Ly-49A+ NK cells after amino acid substitutions in the antigen binding cleft.The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles.
P2860
Q22003745-6BF776FB-7948-47F6-B532-C6A7623BF442Q22010576-1CC398F5-E71D-4AB7-A7DA-11877996B99DQ24310017-92235936-B44A-4CC7-88ED-B565063F473FQ24310824-54CA60E2-5A74-42F7-B1B8-EF2304AC5C2DQ24315619-0D8903F2-3F35-41DE-BBD5-AE4AC64FC125Q24320182-FED5BF61-6265-4498-85AE-8B5D220CDD85Q24329103-7A7F347B-B0F5-424A-B0CC-93DA9DC31FD4Q24670229-2B4B3896-205D-4820-90E0-EA39365ED812Q24675903-AEE6F4AB-E6C5-433F-8982-4FA4A16F8D5BQ24676716-8858FC82-7A63-4DD6-B98D-C058FE0FEAC0Q26999306-F786579F-EFAD-426A-BF3A-84395FCF3BE9Q28138946-28D2EB45-2419-4B0E-90FE-B64D01C31B57Q28263470-79238D1E-A2C9-4A19-8D2F-6D97EC224A93Q28590300-EA294BCA-A3D6-4864-80C5-8FF31C2F6A7DQ33607045-F39F4478-14FE-45AE-85AD-834BA5C60F20Q33644460-F3B5FFCC-F42D-4B8A-9D49-FCA3AF273B4EQ33753703-61D9A4C5-9D26-4515-A32D-4ACC5B5D15DEQ33769518-8084CA64-4148-4A7D-B386-49C3B514E319Q33890583-5F00AF3A-0B04-4232-BAF3-D329F853BB79Q34064605-27A87218-C17F-412A-BE2C-4B8FC4FFA6A3Q34065286-95BDD93E-A4D9-417E-8C59-011E03398685Q34265200-2F693724-BFFB-4EB1-9FAC-F23310942A83Q34592455-91B33E08-204A-47DA-81C1-6EF701A61949Q36064217-A1A9E7EE-FF25-453C-AF03-60020BF2AD8CQ36065870-8A4165FD-F39E-48AD-BE49-0BE5E8054CF4Q36183939-8212EFF6-C2D0-4B7D-A5B0-F09F45D89C90Q36364483-53CC78C5-64BB-4190-B18A-CD9763EDECD4Q36377146-1E8AD052-3F81-4E50-9297-D7EB1C9F761BQ36380304-BE5793BE-0F05-4138-9321-33C7FE11DB94Q36400442-4241357E-EF3A-4327-8221-623E2975EA54Q36400815-E42A76F2-5AE2-465C-AF7F-7BD7F9CC0F1AQ36453656-00076335-6DD8-4431-85E4-59C1A46A7873Q36652161-B5E46AEF-F25F-4BA3-B2F3-EB6F4A2F83B4Q37399943-0FD63510-B689-4297-896C-0BCC660365F5Q37754682-E9F44137-A1AE-4AF1-A7BE-C2AEC3DC6B3CQ38568874-09B70CB0-9B8D-4430-A028-78CB75489271Q38864935-B7393982-5506-4BE9-B6E4-0BB36DCC2A10Q40359957-9D71C753-6270-4D96-97AB-3CA65DDD6129Q41005847-84CA5EC5-85D8-49B2-AB3B-204DA93C2797Q41013301-727F6F51-DA76-4369-9A42-C3C880198090
P2860
CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
CD94 and a novel associated pr ...... -A, HLA-B, and HLA-C allotypes
@ast
CD94 and a novel associated pr ...... -A, HLA-B, and HLA-C allotypes
@en
CD94 and a novel associated pr ...... -A, HLA-B, and HLA-C allotypes
@nl
type
label
CD94 and a novel associated pr ...... -A, HLA-B, and HLA-C allotypes
@ast
CD94 and a novel associated pr ...... -A, HLA-B, and HLA-C allotypes
@en
CD94 and a novel associated pr ...... -A, HLA-B, and HLA-C allotypes
@nl
prefLabel
CD94 and a novel associated pr ...... -A, HLA-B, and HLA-C allotypes
@ast
CD94 and a novel associated pr ...... -A, HLA-B, and HLA-C allotypes
@en
CD94 and a novel associated pr ...... -A, HLA-B, and HLA-C allotypes
@nl
P2093
P1433
P1476
CD94 and a novel associated pr ...... -A, HLA-B, and HLA-C allotypes
@en
P2093
P304
P356
10.1016/S1074-7613(00)80492-6
P407
P577
1996-08-01T00:00:00Z